Literature DB >> 20495876

Quality of life of patients with oesophageal cancer in Taiwan: validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: a brief communication.

Wei-Chu Chie1, Chia-Jih Tsai, Chieh Chiang, Yung-Chie Lee.   

Abstract

PURPOSE: The aim of this study was to examine the reliability and validity, and the application of the Taiwan Chinese Version of the EORTC QLQ-OES18.
METHODS: The authors translated the questionnaire according to the guideline of the EORTC. Ninety-five patients with oesophageal cancer in National Taiwan University Hospital were interviewed using the questionnaire and the EORTC QLQ-C30 between October 2002 and September 2007. Answer distribution and psychometric properties of the EORTC QLQ-OES18 were examined.
RESULTS: The mean age of the patients was 60 years (SD 12 years). Most of the patients were in advanced stages of disease, with two-thirds off-treatment. The Cronbach's alpha coefficients were satisfactory (0.77-0.82) or near-satisfactory (pain: 0.67). The item-to-own and item-to-other scale correlations showed satisfactory results. Patients who were on-treatment versus off-treatment had significantly poorer quality of life scores in dysphagia, dry mouth, and taste, and a borderline poorer score in cough. Opposite situations were seen in the scales of reflux and choking.
CONCLUSIONS: The EORTC QLQ-OES18 is a valid instrument to assess quality of life issues in patients with oesophageal cancer in Taiwan.

Entities:  

Mesh:

Year:  2010        PMID: 20495876     DOI: 10.1007/s11136-010-9675-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  23 in total

1.  Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement.

Authors:  M Groenvold; M C Klee; M A Sprangers; N K Aaronson
Journal:  J Clin Epidemiol       Date:  1997-04       Impact factor: 6.437

Review 2.  Esophageal cancer.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Curr Probl Surg       Date:  1997-10       Impact factor: 1.909

3.  Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.

Authors:  J M Blazeby; D Alderson; K Winstone; R Steyn; E Hammerlid; J Arraras; J R Farndon
Journal:  Eur J Cancer       Date:  1996-10       Impact factor: 9.162

4.  Predictors of postoperative quality of life after esophagectomy for cancer.

Authors:  Therese Djärv; Jane M Blazeby; Pernilla Lagergren
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

5.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

6.  Malnutrition after oesophageal cancer surgery in Sweden.

Authors:  L Martin; J Lagergren; M Lindblad; I Rouvelas; P Lagergren
Journal:  Br J Surg       Date:  2007-12       Impact factor: 6.939

7.  Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.

Authors:  Pernilla Lagergren; Peter Fayers; Thierry Conroy; Hubert J Stein; Orhan Sezer; Richard Hardwick; Eva Hammerlid; Andrew Bottomley; Eric Van Cutsem; Jane M Blazeby
Journal:  Eur J Cancer       Date:  2007-08-15       Impact factor: 9.162

8.  Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.

Authors:  G Apolone; A Filiberti; S Cifani; R Ruggiata; P Mosconi
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

9.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

Authors:  M J Hjermstad; S D Fossa; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

10.  Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation.

Authors:  H Bergquist; A Johnsson; E Hammerlid; U Wenger; L Lundell; M Ruth
Journal:  Aliment Pharmacol Ther       Date:  2007-12-09       Impact factor: 8.171

View more
  6 in total

1.  Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer.

Authors:  Yu-Ling Chang; Yun-Fang Tsai; Yin-Kai Chao; Meng-Yu Wu
Journal:  Qual Life Res       Date:  2015-08-04       Impact factor: 4.147

2.  Adaptation of a quality of life questionnaire for Iranian patients with esophageal cancer.

Authors:  Mojgan Forootan; Morteza Tabatabaeefar; Nakisa Maghsoodi; Maryam Ardeshiri; Mahdi Fatemi; Hormat Rahimzadeh
Journal:  Indian J Palliat Care       Date:  2014-05

3.  Functional outcomes and quality of life after a 6-month early intervention program for oral cancer survivors: a single-arm clinical trial.

Authors:  Yueh-Hsia Chen; Wei-An Liang; Chung-Yin Hsu; Siang-Lan Guo; Shwu-Huei Lien; Hsiao-Jung Tseng; Yuan-Hung Chao
Journal:  PeerJ       Date:  2018-02-21       Impact factor: 2.984

4.  Validation of the Turkish version of European Organization for Research and Treatment of Cancer QLQ-OV28 ovarian cancer specific quality of life questionnaire.

Authors:  Yeşim Akdemir; Çetin Cam; Nadiye Pınar Ay; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2020-04-06

5.  Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.

Authors:  Ming-Hung Shen; Ling-Ping Chen; Thien-Fiew Ho; Ying-Yih Shih; Ching-Shui Huang; Wei-Chu Chie; Chi-Cheng Huang
Journal:  BMC Cancer       Date:  2018-04-02       Impact factor: 4.430

6.  Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.

Authors:  Ying-Ying Zheng; Ting Zhang; Zhi-Rong Yang; Qiuling Shi; Xin Shelley Wang; Jun Zhao; Min Yang; Chun-Lin Wu; Guo-Rong Wang
Journal:  BMC Womens Health       Date:  2021-07-29       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.